

Eye drops
1 ml of eye drops 1% contains: methylethylpyridinol hydrochloride (emoxipin) 10 mg.
Excipients: anhydrous sodium sulfite, sodium benzoate, potassium phosphate monosubstituted, sodium phosphate disubstituted, methylcellulose, water d / u.
In a bottle 5 ml drops. In the package 1 bottle.
Emoxypine - an antioxidant for use in ophthalmology.
Emoxypine reduces capillary permeability, strengthens the vascular wall, has a membrane stabilizing effect, inhibits platelet aggregation, reduces clotting and blood viscosity, has antiplatelet and antihypoxic effects.
- and the prevention of inflammation and burns of the cornea.
- Treatment of hemorrhages in the anterior chamber of the eye.
- Treatment of complications of myopia.
- Protection of the cornea when wearing contact lenses.
- Prevention and treatment of hemorrhage in the sclera in the elderly.
- Pregnancy.
- Hypersensitivity to the drug.
The drug is contraindicated for use in pregnancy.Data on the safety of the drug during lactation is not provided.
The drug is instilled into the conjunctival cavity 1-2 drops 2-3 times / day. The course of treatment is 3-30 days. If necessary, and good tolerability of the drug, the treatment can be continued up to 6 months or repeated 2-3 times a year.
Local reactions: burning sensation, itching, short-term conjunctival hyperemia; rarely local allergic reactions.
If necessary, the simultaneous use of other eye drops Emoksipin-AKOS should be instilled last after complete absorption of the preceding drops (no less than 10-15 minutes).
A solution of Emoxypine should not be mixed with solutions of other drugs.
The drug should be stored in a dark place at a temperature below 25 ° C.
Emoxypine Ophthalmic